Parkinson's & Movement disorders

Finding right drug balance for Parkinson's patients

Parkinson's disease is most commonly treated with levodopa, a drug which alleviates the slowing of bodily movements, called bradykinesia, found in Parkinson's disease patients.

Neuroscience

New study on development of Parkinson's disease is 'on the nose'

The loss of a sense of smell is known to be one of the earliest signs of Parkinson's disease (PD) and can even appear years before the characteristic tremors and loss of motor function are seen. Some scientists believe that ...

Psychology & Psychiatry

Dopamine neurons mull over your options

In "Indiana Jones and the Last Crusade," Indiana must choose his grail "wisely," as a poor choice spells instant death. According to a new study by Professor Masayuki Matsumoto at the University of Tsukuba, making these kinds ...

Psychology & Psychiatry

Novelty speeds up learning thanks to dopamine activation

Brain scientists led by Sebastian Haesler (NERF, empowered by IMEC, KU Leuven and VIB) have identified a causal mechanism of how novel stimuli promote learning. Novelty directly activates the dopamine system, which is responsible ...

Neuroscience

Parkinson's disease may start before birth

People who develop Parkinson's disease before age 50 may have been born with disordered brain cells that went undetected for decades, according to new Cedars-Sinai research. The research points to a drug that potentially ...

page 6 from 23